Neuronetics Stock Price Patterns
| STIM Stock | USD 1.32 -0.06 -4.35% |
Momentum 38
Sell Extended
Oversold | Overbought |
The hype perspective for Neuronetics maps headline activity to recent price response and peer coverage.
This view highlights attention trends for Neuronetics using headlines and public commentary as context.
Neuronetics after-hype prediction price | USD 1.32 |
Sentiment metrics here complement forecasting and technical views with analyst and earnings context.
Neuronetics | Build AI portfolio with Neuronetics Stock |
The mean reversion principle applied to Neuronetics' suggests that neither prolonged outperformance nor underperformance is permanent. Investors exploit this by positioning against extremes in price relative to fundamental value.
Neuronetics After-Hype Price Density Analysis
Probability distributions applied to Neuronetics price forecasting provide a more honest representation of uncertainty than single point estimates. The shape of Neuronetics' distribution - whether it is symmetric, skewed, or fat-tailed - carries important information for risk.
Next price density |
| Expected price to next headline |
Neuronetics Estimiated After-Hype Price Volatility
News-driven price analysis for Neuronetics quantifies the historical relationship between headline events and Neuronetics' short-term price response. Neuronetics' after-hype downside and upside margins for the prediction period are 0.07 and 8.58, respectively. The strength of this signal depends on the consistency of Neuronetics's past reactions to comparable news categories.
Current Value
The after-hype framework applied to Neuronetics assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Neuronetics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Neuronetics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Neuronetics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Neuronetics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.23 | 7.26 | 0.00 | 0.00 | 0 Events | 1 Events | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.32 | 1.32 | 0.00 |
|
Neuronetics Hype Timeline
Neuronetics is at this time traded for 1.32. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Neuronetics is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.23%. %. The volatility of related hype on Neuronetics is about 34571.43%, with the expected price after the next announcement by competition of 1.32. About 20.0% of the company outstanding shares are owned by corporate insiders. The book value of Neuronetics was at this time reported as 0.4. The company recorded a loss per share of 0.83. Neuronetics had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be within a week. Neuronetics Basic Forecasting Models can be used to cross-verify projections for Neuronetics. The models provide an additional statistical reference.Neuronetics Related Hype Analysis
When a direct competitor of Neuronetics experiences a significant news event, the market often re-rates Neuronetics' shares in sympathy or in contrast, depending on whether the news affects the sector broadly or competitively.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PRE | Prenetics Global | 0.00 | 0 per month | 4.24 | 0.13 | 13.33 | -7.28 | 27.11 | |
| NYXH | Nyxoah | 0.00 | 0 per month | 0.00 | -0.14 | 5.07 | -6.21 | 21.88 | |
| ATLN | Atlantic International Corp | 0.00 | 0 per month | 5.37 | 0.16 | 18.21 | -9.97 | 64.87 | |
| OABI | OmniAb Inc | 0.00 | 0 per month | 0.00 | -0.01 | 5.29 | -5.37 | 16.00 | |
| CATX | Perspective Therapeutics | -0.33 | 11 per month | 4.89 | 0.18 | 11.81 | -8.83 | 77.44 | |
| OSUR | OraSure Technologies | 0.12 | 8 per month | 2.10 | 0.16 | 5.98 | -3.35 | 16.03 | |
| PROF | Profound Medical Corp | 0.00 | 0 per month | 0.00 | -0.08 | 5.94 | -7.33 | 38.55 | |
| CDXS | Codexis | 0.00 | 0 per month | 0.00 | -0.1 | 7.02 | -7.74 | 24.68 | |
| SGMO | Sangamo Therapeutics | 0.00 | 0 per month | 6.19 | 0.01 | 7.45 | -7.50 | 73.25 | |
| GNFT | Genfit SA | 0.00 | 0 per month | 3.66 | 0.06 | 6.50 | -7.18 | 25.18 |
Neuronetics Additional Predictive Modules
Most predictive techniques to examine Neuronetics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Neuronetics using various technical indicators. When you analyze Neuronetics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Is Neuronetics in the News?
Sentiment analysis for Neuronetics evaluates news tone, positioning, and narrative momentum. Narrative alignment can reinforce trend persistence in certain regimes. We review the company from a portfolio-construction standpoint emphasizing diversification and stability.
Methodology
Unless otherwise specified, financial data for Neuronetics is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Neuronetics (USA Stocks:STIM) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Analyst consensus data and sentiment signals are derived from publicly available research and media sources and reflect a point-in-time view.
Assumptions
Macroaxis analytics incorporate public filings and market reference sources and official disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data harmonization may result in minor timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.Analyst Sources
Neuronetics may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetMore Resources for Neuronetics Stock Analysis
Understanding Neuronetics typically begins with financial statements and long-term trend review. Ratio context helps frame profitability, efficiency, and growth trends for Neuronetics Stock. Outlined below are key reports that provide context for Neuronetics Stock:Neuronetics Basic Forecasting Models can be used to cross-verify projections for Neuronetics. The models provide an additional statistical reference. New to investing in Neuronetics Stock? Start with our How to Invest in Neuronetics Stock guide for a step-by-step overview.Analysis related to Neuronetics should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Neuronetics market price can diverge from book value, the accounting figure shown on Neuronetics balance sheet. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Market price can move with sentiment, cycles, and liquidity conditions, so it may drift away from fundamentals. Valuation methods compare these perspectives to frame context.
It is useful to distinguish Neuronetics' value from its trading price, which are computed with different methods. Analysis often considers earnings, revenue quality, fundamentals, technical signals, competition, and analyst coverage. The quoted price is simply the exchange level where supply meets demand.